SATB1 was also associated with a worse prognosis in cancers, like laryngeal squamous cell carcinoma (LSCC)(in mucosal cells) (167), endometrioid endometrial cancer (EEC) (in EEC cells) (168), hepatocellular carcinoma (HCC)(in human hepatocarcinoma tissue and liver cancer cell lines) (169), rectal cancer (in human rectal cancer tissues) (170), cutaneous malignant melanoma (CMM)(in primary CMM cells) (171), gastric cancer (in gastric cancer cells) (172) and prostate cancer (173). Here, SATB1 is linked to rectal cancer.